https://www.thebodypro.com/collection/croi-2020
stem cell transplant device
Conference Coverage

Durable HIV Remission in London Patient, the Second Person Cured of HIV

Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.

By Sony Salzman

Featured

pregnant check-up
Conference Coverage

Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed

Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.

By Barbara Jungwirth
vaginal ring
Conference Coverage

Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals

A CROI 2020 roundup of studies on birth control and women living with HIV.

By Barbara Jungwirth
pregnant belly
Conference Coverage

Tempering Previous Concerns, Study Finds Dolutegravir Safest HIV Treatment During Pregnancy

New data shows the drug is not more likely to cause birth defects.

By Sony Salzman
vaccine trial
Conference Coverage

Researchers Discuss the Lessons of the HIV Vaccine Trial That Terminated Earlier This Year

HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.

By Barbara Jungwirth
coronary atherosclerosis
Conference Coverage

Recent Initiation of Testosterone Therapy Linked to Greater Atherosclerosis Progression in MSM With HIV

New findings contribute to the indication that people with HIV taking testosterone therapy should be counseled on the cardiovascular risks.

By Myles Helfand
birthday candles
News Analysis

HIV Life Expectancy in U.S. Now Matches General Population—With Some Big “Buts”

The biggest may be that more of an HIV-positive person’s equally long lifespan will be spent managing comorbidities, one large study found.

By Myles Helfand
holding hands
Conference Coverage

Scientists Report Documented Sustained HIV Remission in a 4-Year-Old Child

Treating newborns with antiretroviral therapy in the hours after birth may help put HIV into remission.

By Sony Salzman
injectable
Conference Coverage

The Monthly Injectable HIV Drug Works Just as Well When Given Every Two Months

Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.

By Sony Salzman
Marrazzo at CROI
News

CROI 2020: What to Expect in HIV Science From This Year’s Conference

COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.

By Sony Salzman